1. Home
  2. AVDL vs AOD Comparison

AVDL vs AOD Comparison

Compare AVDL & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • AOD
  • Stock Information
  • Founded
  • AVDL 2015
  • AOD 2006
  • Country
  • AVDL Ireland
  • AOD United States
  • Employees
  • AVDL N/A
  • AOD N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • AOD Investment Managers
  • Sector
  • AVDL Health Care
  • AOD Finance
  • Exchange
  • AVDL Nasdaq
  • AOD Nasdaq
  • Market Cap
  • AVDL 993.5M
  • AOD 918.3M
  • IPO Year
  • AVDL 1996
  • AOD N/A
  • Fundamental
  • Price
  • AVDL $10.48
  • AOD $8.62
  • Analyst Decision
  • AVDL Strong Buy
  • AOD
  • Analyst Count
  • AVDL 6
  • AOD 0
  • Target Price
  • AVDL $24.00
  • AOD N/A
  • AVG Volume (30 Days)
  • AVDL 1.1M
  • AOD 301.9K
  • Earning Date
  • AVDL 11-12-2024
  • AOD 01-01-0001
  • Dividend Yield
  • AVDL N/A
  • AOD 8.43%
  • EPS Growth
  • AVDL N/A
  • AOD N/A
  • EPS
  • AVDL N/A
  • AOD N/A
  • Revenue
  • AVDL $138,160,000.00
  • AOD N/A
  • Revenue This Year
  • AVDL $523.86
  • AOD N/A
  • Revenue Next Year
  • AVDL $70.46
  • AOD N/A
  • P/E Ratio
  • AVDL N/A
  • AOD N/A
  • Revenue Growth
  • AVDL 1523.50
  • AOD N/A
  • 52 Week Low
  • AVDL $9.41
  • AOD $7.02
  • 52 Week High
  • AVDL $19.09
  • AOD $8.45
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 46.37
  • AOD 48.98
  • Support Level
  • AVDL $9.97
  • AOD $8.31
  • Resistance Level
  • AVDL $10.53
  • AOD $8.71
  • Average True Range (ATR)
  • AVDL 0.47
  • AOD 0.10
  • MACD
  • AVDL 0.12
  • AOD 0.01
  • Stochastic Oscillator
  • AVDL 61.43
  • AOD 67.35

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest

Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. It predominantly invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, Industrials among other sectors.

Share on Social Networks: